{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:45:23Z","timestamp":1788691523090,"version":"build-2803163510"},"reference-count":99,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Lung transplantation for people with cystic fibrosis (PwCF) is a critical therapeutic option, in a disease without a cure to this day, and its overall success in this population is evident. The medical advancements in knowledge, treatment, and clinical care in the field of cystic fibrosis (CF) rapidly expanded and improved over the last several decades, starting from early pathology reports of CF organ involvement in 1938, to the identification of the CF gene in 1989. Lung transplantation for CF has been performed since 1983, and CF now accounts for about 17% of pre-transplantation diagnoses in lung transplantation recipients. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have been the latest new therapeutic modality addressing the underlying CF protein defect with the first modulator, ivacaftor, approved in 2012. Fast forward to today, and we now have a growing CF population. More than half of PwCF are now adults, and younger patients face a better life expectancy than they ever did before. Unfortunately, CFTR modulator therapy is not effective in all patients, and efficacy varies among patients; it is not a cure, and CF remains a progressive disease that leads predominantly to respiratory failure. Lung transplantation remains a lifesaving treatment for this disease. Here, we reviewed the current knowledge of lung transplantation in PwCF, the challenges associated with its implementation, and the ongoing changes to the field as we enter a new era in the care of PwCF. Improved life expectancy in PwCF will surely influence the role of transplantation in patient care and may even lead to a change in the demographics of which people benefit most from transplantation.<\/jats:p>","DOI":"10.3390\/life13071600","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:57:30Z","timestamp":1690160250000},"page":"1600","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lung Transplantation in a New Era in the Field of Cystic Fibrosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-7863","authenticated-orcid":false,"given":"Alexander T.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Korotun","sequence":"additional","affiliation":[{"name":"Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Iacono","sequence":"additional","affiliation":[{"name":"Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"},{"name":"Institute of Health System Science, Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY 11030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: A worldwide analysis of CFTR mutations\u2014correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum. Mutat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Gray","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1093\/nar\/19.19.5417","article-title":"Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin","volume":"19","author":"Yoshimura","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"30926","DOI":"10.1038\/srep30926","article-title":"Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Ganglia of Human Gastrointestinal Tract","volume":"6","author":"Xue","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"L917","DOI":"10.1152\/ajplung.00326.2014","article-title":"CFTR and lung homeostasis","volume":"307","author":"Collawn","year":"2014","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"Amaral","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_7","unstructured":"(2023, June 01). Cystic Fibrosis Foundation Patient Registry 2021 Annual Data Report. Bethesda, Maryland. Available online: https:\/\/www.cff.org\/sites\/default\/files\/2021-11\/Patient-Registry-Annual-Data-Report.pdf."},{"key":"ref_8","first-page":"122","article-title":"Cystic Fibrosis Therapy: From Chest Physiotherapy to Agents Targeting Specific Mutations","volume":"2","author":"Wang","year":"2020","journal-title":"Eur. J. Respir. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(98)70441-X","article-title":"Comparison of the clinical manifestations of cystic fibrosis in black and white patients","volume":"132","author":"Hamosh","year":"1998","journal-title":"J. Pediatr."},{"key":"ref_10","unstructured":"(2023, March 09). About Cystic Fibrosis|Cystic Fibrosis Foundation. Available online: https:\/\/www.cff.org\/intro-cf\/about-cystic-fibrosis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200410-1369OC","article-title":"Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation","volume":"173","author":"Belkin","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-0039-1694021","article-title":"Cystic Fibrosis: Pathophysiology of Lung Disease","volume":"40","author":"Bergeron","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: The 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_14","unstructured":"(2023, March 09). Understanding Changes in Life Expectancy|Cystic Fibrosis Foundation. Available online: https:\/\/www.cff.org\/managing-cf\/understanding-changes-life-expectancy."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jama.1963.03710120070015","article-title":"Lung transplantation","volume":"186","author":"Griscom","year":"1963","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report\u20142021; Focus on recipient characteristics","volume":"40","author":"Chambers","year":"2021","journal-title":"J. Heart Lung Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J. Heart Lung Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease","volume":"350","author":"Celli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1053-2498(01)00241-8","article-title":"Listing for lung transplantation: Life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience","volume":"20","author":"Smits","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1378\/chest.07-0011","article-title":"Organ Allocation in Lung Transplant","volume":"132","author":"Davis","year":"2007","journal-title":"Chest"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.healun.2016.01.010","article-title":"Effect of the lung allocation score on lung transplantation in the United States","volume":"35","author":"Egan","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.healun.2022.05.008","article-title":"The lung allocation score and other available models lack predictive accuracy for post-lung transplant survival","volume":"41","author":"Brahmbhatt","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.chest.2017.01.019","article-title":"Heterogeneity in Survival in Adult Patients with Cystic Fibrosis With FEV1 < 30% of Predicted in the United States","volume":"151","author":"Ramos","year":"2017","journal-title":"Chest"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12055-021-01156-7","article-title":"Donation after circulatory death (DCD)\u2014Lung procurement","volume":"37","author":"Keshavamurthy","year":"2021","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.21037\/jtd.2017.07.82","article-title":"Donors after cardiocirculatory death and lung transplantation","volume":"9","author":"Inci","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.healun.2019.01.121","article-title":"Increasing Use of EVLP in the United States: Data from the OPTN\/UNOS","volume":"38","author":"Lehman","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/rccm.201907-1385ED","article-title":"Call for Changes in Lung Allocation to Reduce Transplant Wait-List Mortality for Cystic Fibrosis","volume":"200","author":"Nolley","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/rccm.201902-0252OC","article-title":"Effect of Including Important Clinical Variables on Accuracy of the Lung Allocation Score for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease","volume":"200","author":"Lehr","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_31","unstructured":"(2023, April 17). Lung Allocation Based on the Composite Allocation Score (CAS): Questions and Answers for Patients and Caregivers\u2014OPTN, Available online: https:\/\/optn.transplant.hrsa.gov\/patients\/by-organ\/lung\/lung-allocation-based-on-the-composite-allocation-score-cas-questions-and-answers-for-patients-and-caregivers\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1111\/ajt.17160","article-title":"Expected effect of the lung Composite Allocation Score system on US lung transplantation","volume":"22","author":"Valapour","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jcf.2023.02.011","article-title":"Position paper: Models of post-transplant care for individuals with cystic fibrosis","volume":"22","author":"McKone","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2021.04.011","article-title":"Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients","volume":"40","author":"Shah","year":"2021","journal-title":"J. Heart Lung Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.109.3.787","article-title":"Lung Transplantation for Cystic Fibrosis","volume":"109","author":"Kotloff","year":"1996","journal-title":"Chest"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-016-0529-6","article-title":"Infectious Triggers of Chronic Lung Allograft Dysfunction","volume":"18","author":"Gregson","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment","volume":"9","author":"Verleden","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12055-021-01178-1","article-title":"Early postoperative complications in lung transplant recipients","volume":"38","author":"Soetanto","year":"2022","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/mr.60.3.539-574.1996","article-title":"Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia","volume":"60","author":"Govan","year":"1996","journal-title":"Microbiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10096-009-0774-9","article-title":"Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis","volume":"28","author":"Dales","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.healun.2007.05.018","article-title":"Survival of Lung Transplant Patients with Cystic Fibrosis Harboring Panresistant Bacteria Other Than Burkholderia cepacia, Compared with Patients Harboring Sensitive Bacteria","volume":"26","author":"Hadjiliadis","year":"2007","journal-title":"J. Heart Lung Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/pathogens3030680","article-title":"Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs\u2014A Review","volume":"3","author":"Sousa","year":"2014","journal-title":"Pathogens"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.rmed.2008.11.015","article-title":"Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis","volume":"103","author":"Gottlieb","year":"2009","journal-title":"Respir. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.173.4.2231","article-title":"Cutting Edge: Expression of Chemokine Receptor CXCR1 on Human Effector CD8+ T Cells","volume":"173","author":"Takata","year":"2004","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhin.2004.01.003","article-title":"The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: Results from a single large referral centre","volume":"56","author":"Dobbin","year":"2004","journal-title":"J. Hosp. Infect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3389\/fmicb.2017.01592","article-title":"Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches","volume":"8","author":"Scoffone","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1513\/AnnalsATS.202003-204OC","article-title":"Clinical Outcomes Associated with Burkholderia cepacia Complex Infection in Patients with Cystic Fibrosis","volume":"17","author":"Somayaji","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.healun.2010.06.007","article-title":"Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience","volume":"29","author":"Meachery","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1164\/ajrccm.163.1.9811076","article-title":"Infection with Burkholderia cepacia in Cystic Fibrosis: Outcome following lung transplantation","volume":"163","author":"Chaparro","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcf.2008.01.002","article-title":"The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre","volume":"7","author":"France","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_51","first-page":"CD009529","article-title":"Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation","volume":"4","author":"Lord","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_52","unstructured":"(2023, April 21). Nontuberculous Mycobacteria (NTM)|Cystic Fibrosis Foundation. Available online: https:\/\/www.cff.org\/managing-cf\/nontuberculous-mycobacteria-ntm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.2005.049247","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: Implications for lung transplantation","volume":"61","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e13046","DOI":"10.1111\/tid.13046","article-title":"Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series","volume":"21","author":"Raats","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline: Executive Summary","volume":"71","author":"Daley","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2013.02.003","article-title":"What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?","volume":"12","author":"Liu","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.123.3.800","article-title":"Aspergillus Infection in Lung Transplant Recipients with Cystic Fibrosis: Risk factors and outcomes comparison to other types of transplant recipients","volume":"123","author":"Helmi","year":"2003","journal-title":"Chest"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1600-6143.2009.02635.x","article-title":"Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome","volume":"9","author":"Weigt","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","volume":"8","author":"Colombo","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mathew, H.R., Choi, M.Y., Parkins, M.D., and Fritzler, M.J. (2021). Systematic review: Cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01528-0"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcf.2011.10.005","article-title":"Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation","volume":"11","author":"Hofer","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.117.2.476","article-title":"Osteoporosis and Lung Transplantation: A prospective study","volume":"117","author":"Spira","year":"2000","journal-title":"Chest"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.123.1.37","article-title":"GI Complications After Lung Transplantation in Patients with Cystic Fibrosis","volume":"123","author":"Gilljam","year":"2003","journal-title":"Chest"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1053-2498(00)00315-6","article-title":"Nutritional assessment of the lung transplant patient: Body mass index as a predictor of 90\u2013day mortality following transplantation","volume":"20","author":"Madill","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and Constipation in Cystic Fibrosis with a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s11605-009-0924-5","article-title":"Distal Intestinal Obstruction Syndrome (DIOS) in Patients with Cystic Fibrosis After Lung Transplantation","volume":"13","author":"Morton","year":"2009","journal-title":"J. Gastrointest. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1542-3565(04)00169-7","article-title":"Distal intestinal obstruction syndrome in adults with cystic fibrosis","volume":"2","author":"Dray","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_69","first-page":"CD012619","article-title":"Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis","volume":"6","author":"Green","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0035-1547347","article-title":"Lung Transplantation for Cystic Fibrosis: Results, Indications, Complications, and Controversies","volume":"36","author":"Sayah","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ramos, K.J., Somayaji, R., Lease, E.D., Goss, C.H., and Aitken, M.L. (2017). Cystic fibrosis physicians\u2019 perspectives on the timing of referral for lung transplant evaluation: A survey of physicians in the United States. BMC Pulm. Med., 17.","DOI":"10.1186\/s12890-017-0367-9"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2018.10.013","article-title":"Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis","volume":"18","author":"Koutsokera","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/tri.12721","article-title":"Underweight and obesity increase the risk of mortality after lung transplantation: A systematic review and meta-analysis","volume":"29","author":"Upala","year":"2016","journal-title":"Transpl. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccm.2015.11.008","article-title":"Lung Transplantation for Cystic Fibrosis","volume":"37","author":"Morrell","year":"2016","journal-title":"Clin. Chest Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.chest.2019.11.043","article-title":"Underweight Patients with Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation","volume":"157","author":"Ramos","year":"2020","journal-title":"Chest"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ctr.12683","article-title":"Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation: A united network for organ sharing registry study","volume":"30","author":"Kelm","year":"2016","journal-title":"Clin. Transplant."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/tri.12961","article-title":"Thoracic muscle cross-sectional area is associated with hospital length of stay post lung transplantation: A retrospective cohort study","volume":"30","author":"Rozenberg","year":"2017","journal-title":"Transpl. Int."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Jennerich, A.L., Downey, L., Goss, C.H., Kapnadak, S.G., Pryor, J.B., and Ramos, K.J. (2023). Computed tomography body composition and clinical outcomes following lung transplantation in cystic fibrosis. BMC Pulm. Med., 23.","DOI":"10.1186\/s12890-023-02398-4"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.21037\/jtd.2017.07.85","article-title":"Outcomes after lung transplantation","volume":"9","author":"Thabut","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2021.12.002","article-title":"Outcomes following lung re-transplantation in patients with cystic fibrosis","volume":"21","author":"Chan","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/jocs.16365","article-title":"Survival following lung transplantation: A population-based nested case-control study","volume":"37","author":"Iguidbashian","year":"2022","journal-title":"J. Card. Surg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ajt.14422","article-title":"Mechanical Ventilation and Extracorporeal Membrane Oxygenation as a Bridging Strategy to Lung Transplantation: Significant Gains in Survival","volume":"18","author":"Hayanga","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e13281","DOI":"10.1111\/ctr.13281","article-title":"Comprehensive outcomes after lung retransplantation: A single-center review","volume":"32","author":"Halloran","year":"2018","journal-title":"Clin. Transplant."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.athoracsur.2016.09.107","article-title":"Two Decades of Lung Retransplantation: A Single-Center Experience","volume":"103","author":"Hall","year":"2017","journal-title":"Ann. Thorac. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/TXD.0000000000000844","article-title":"Retransplantation Outcomes at a Large Lung Transplantation Program","volume":"4","author":"Ren","year":"2018","journal-title":"Transplant. Direct"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa043204","article-title":"A Randomized Trial of Inhaled Cyclosporine in Lung-Transplant Recipients","volume":"354","author":"Iacono","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"00167","DOI":"10.1183\/23120541.00167-2019","article-title":"A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation","volume":"5","author":"Iacono","year":"2019","journal-title":"ERJ Open Res."},{"key":"ref_88","unstructured":"(2023, May 29). Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03657342?term=inhaled+cyclosporine&cond=chronic+lung+transplant+rejection&draw=2&rank=1."},{"key":"ref_89","unstructured":"(2023, May 29). Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03656926?term=inhaled+cyclosporine&cond=chronic+lung+transplant+rejection&draw=2&rank=2."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.healun.2019.06.025","article-title":"An aging population of patients with cystic fibrosis undergoes lung transplantation: An analysis of the ISHLT Thoracic Transplant Registry","volume":"38","author":"Benden","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1513\/AnnalsATS.202009-1190ED","article-title":"Age at Lung Transplant Impacts Post-Transplant Survival in Cystic Fibrosis; Why?","volume":"18","author":"Clausen","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2016.10.002","article-title":"Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor","volume":"16","author":"Fidler","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jcf.2021.01.007","article-title":"Challenges in the use of highly effective modulator treatment for cystic fibrosis","volume":"20","author":"Ramos","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.healun.2021.08.009","article-title":"CFTR modulator use in post lung transplant recipients","volume":"40","author":"Benninger","year":"2021","journal-title":"J. Heart Lung Transplant."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.jcf.2021.05.008","article-title":"Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis","volume":"21","author":"Smith","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease","volume":"56","author":"Andersen","year":"1938","journal-title":"Am. J. Dis. Child."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: Chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(88)92290-8","article-title":"Heart-lung transplantation for cystic fibrosis","volume":"332","author":"Scott","year":"1988","journal-title":"Lancet"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/7\/1600\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:16:35Z","timestamp":1760127395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/7\/1600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":99,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["life13071600"],"URL":"https:\/\/doi.org\/10.3390\/life13071600","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}